Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529835 · ClinicalTrials.gov registry record · NA
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
A NA study of Peripheral Nerve Injuries, sponsored by Auxilium Biotechnologies.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 6
- Study locations
NCT06529835 is a NA study of Peripheral Nerve Injuries that is actively recruiting participants, run by Auxilium Biotechnologies. The registered enrollment target is 80 participants, below the 452-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (82% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT06529835, a NA study of Peripheral Nerve Injuries, is actively recruiting participants, sponsored by Auxilium Biotechnologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
Conditions Studied
Interventions
- DEVICE NeuroSpan Bridge
- DEVICE NeuroGen Nerve Guide
- DEVICE Nerve Autograft
Study Locations (6)
California
- UCSF Orthopedic Institute - San Francisco
Maryland
- Medstar Union Memorial Hospital- The Curtis National Hand Center - Baltimore
New York
- NYU Langone Orthopedic Center - New York
Ohio
- OSU Wexner Medical Center - Columbus
Pennsylvania
- University of Pennsylvania- Penn Presbyterian Medical Center - Philadelphia
Texas
- The San Antonio Orthopaedic Group (TSAOG Orthopaedics) - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-03-21 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06529835
The ClinicalTrials.gov registry entry for NCT06529835 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (82% lower). The listed sponsor is Auxilium Biotechnologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Nerve Injuries appearing as the primary indexed condition, and to 3 interventions - of which NeuroSpan Bridge is the first listed.
NCT06529835 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Maryland, New York.
Frequently Asked Questions
What is clinical trial NCT06529835 about?
NCT06529835 is a clinical study titled "A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair". This is a multicenter, prospective, randomized, subject and evaluator blinded clinical trial to asses the efficacy of Auxilium's NeuroSpan Bridge.
What is the current status of trial NCT06529835?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-03-21. Estimated completion is 2028-08.
What conditions does trial NCT06529835 study?
This clinical trial studies the following conditions: Peripheral Nerve Injuries.
What interventions are being tested in trial NCT06529835?
The interventions under investigation include: NeuroSpan Bridge (DEVICE), NeuroGen Nerve Guide (DEVICE), Nerve Autograft (DEVICE).
Who is sponsoring clinical trial NCT06529835?
This trial is sponsored by Auxilium Biotechnologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529835 being conducted?
This trial has 6 study locations across California, Maryland, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Nerve Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
RECRUITING · NA
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
RECRUITING · Phase 2
-
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
RECRUITING · Phase 2
-
Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.